бренциале форте

бренциале форте Medicine

Contraindications

Hypersensitivity.

Undesirable effects

Nausea, gastralgia, allergic reactions.

Therapeutic indications

Hepatitis (acute and chronic), fatty liver dystrophy in diabetes mellitus, chronic infections, etc., hepatitis (toxic, alcoholic), cirrhosis of the liver, toxicosis of pregnant women, radiation sickness, psoriasis, intoxication, including drug intoxication, impaired liver function in somatic diseases (as part of complex therapy).

Pharmacotherapeutic group

  • Hepatoprotectors

Pharmacodynamic properties

Improves liver function, including detoxification, inhibits the formation of connective tissue in the liver.

Special precautions for storage

In a dry place, at a temperature not exceeding 25 °C.

Keep out of reach of children.

The shelf life of the drug Bronchiale® forte3 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

1 capsule contains phospholipids from soy beans 300 mg, in a contour cell package of 10 pcs. , in a cardboard pack of 3 packages.

Nosological classification (ICD-10)

  • B19 Viral hepatitis, unspecified
  • K70 Alcoholic liver disease
  • K71 Toxic liver damage
  • K72. 9 Liver failure, unspecified
  • K74 Fibrosis and cirrhosis of the liver
  • K76. 0 Fatty liver degeneration, not classified elsewhere
  • K76. 9 Liver disease, unspecified
  • L40 Psoriasis
  • O95-O99 Other obstetric conditions not classified elsewhere
  • T66 Unspecified radiation effects
  • X40-X49 Accidental poisoning and exposure to toxic substances

Dosage (Posology) and method of administration

Inside, during meals with a small amount of water, 600 mg 2-3 times a day. The course of treatment is 3 months. If necessary, the course of treatment can be continued or repeated only after consultation with a doctor.

ATC - Anatomical and therapeutic chemical classification

A05C Drugs for the treatment of liver and biliary tract diseases in combination